Health policy analysis
Program overview:
The health policy analysis group of the Health Systems Science Program seeks to understand and improve how agendas are set, policies are developed, and how these policies can shape - and be shaped by- health systems, societal understanding of health, and its determinants.
The group is transdisciplinary in nature, and integrates expertise across health economics, sociology, political science, public health, international relations, modelling and qualitative research to conduct health policy analysis across the spectrum to conduct policy analysis across a range of approaches such as:
Outcome oriented approaches: with the intent to identify the 'best' policy solution, through undertaking objective analyses of possible solutions by mapping or quantitatively assessing effectiveness, equity, or feasibility of implementing policies
Mainstream approaches: to identify and analyse actors, interactions between them policy process and or to analyse how power and re
Our Innovation
Healthcare around the world is changing. Improvements in technology, diagnostics and treatments mean that many people around the world are living longer, healthier lives.
But not everyone is able to benefit, and significant health inequities remain. We’re harnessing the power of innovation to tackle the world’s most pressing health challenges, with a focus on those who need them most.
By combining quality research, emerging technologies, and strategic partnerships, we are transforming innovative ideas into real-world solutions.
From enhancing healthcare delivery to addressing unmet global health needs, we aim to create lasting impact through collaboration and creativity.
Cydonie Greenaway Genovate program manager at The George Institute, on stage at the UNSW Founders Health10x awards
Key areas of innovation
Re-imagining large scale clinical trial design, boosting diagnostic accuracy with AI and building the skills of tomorrow’s leaders are just some of t
15 Years of SMARThealth: Building capacity, strengthening systems, improving lives
SMARThealth offers a new approach to disease detection, management and treatment – strengthening primary care systems, building the capacity of health workers, and improving health outcomes for patients. SMARThealth (Systematic Medical Appraisal, Referral and Treatment for common health conditions) was developed by The George Institute for the management of chronic diseases. It leverages a low-cost, digital platform which can be used by health workers to significantly improve patient care, especially in contexts where health services are limited.
Deployed on hand-held digital devices, SMARThealth uses evidence-based algorithms and guidelines to help community health workers assess chronic disease risks for people in their communities. People identified to be needing further care are then referred via the platform for clinician follow up.
Extending SMARThealth
The first iteration of SMARThealth was ‘HealthTracker’ used in Australia in 2009 to analyse the electronic health records o
Using pregnancy to improve women’s lifelong health
By utilising a life-course approach to the prevention of non-communicable diseases, when women are screened during pregnancy.
The physiological changes in a woman’s body during pregnancy to support fetal growth and wellbeing and prepare for labour and birth have been compared to a nine-month marathon that finishes with a sprint. For some women, this pregnancy “stress test” will result in medical complications of pregnancy, such as gestational diabetes (“GDM”, affecting approximately 1 in 7 pregnancies globally), high blood pressure disorders (affecting up to 1 in 10 pregnancies globally) and anaemia (10-40%). Existing mental and physical health conditions may also worsen.
The course of a woman’s pregnancy also gives a window into a woman’s future health, as the effect of pregnancy complications on mother and child do not end with the pregnancy. For example, after hypertensive pregnancy there is at least doubled risk of cardiovascular disease (beginning within 5-10 years of
Improve outcomes for women specific conditions globally
Globally efforts to improve women’s health largely focus on maternal health, overlooking women’s health needs beyond pregnancy and childbirth. The weight given to the maternal health outcome neglects the full range of women’s health. Diseases that affect women are substantially under-studied and under resourced. Gynaecological cancers and conditions like endometriosis, uterine fibroids, poly cystic syndrome, and cervical cancers might have been better understood if they also affected men. Since these are women-specific health issues that affect a woman’s quality of life across her lifespan, there has been little investment, particularly in low-and middle-income countries, to improve early diagnosis and treatment. For example, approximately 180 women globally with endometriosis remain undiagnosed and suffer from its symptoms like pain and infertility for almost seven years before getting diagnosed. Hence, more research and concerted action is needed to improve women’s health and to ensure tha
Changing policy and practice
We conduct large scale work to influence global health policies and practice.
For example, a large scale cohort study recruiting 40,000 people in 21 low and middle-income countries is informing development of better fracture care in resource-poor settings. In India, we have reviewed national injury surveillance systems and made recommendations to Government regarding their strengthening and expansion. We evaluated the pilot cashless scheme of health insurance for road crashes victims and made recommendations for effective coverage and performance benchmarking. The findings have contributed to expansion of the scheme across all National Highway’s in India , under the Motor Vehicle (Amendment) bill 2016.
Designing and operationalising trials
The George Institute has a highly skilled team which works to conceptualise, develop, and deliver innovative and impactful clinical trials, characterised by the following features:
Reducing trial ‘waste’
Ensuring that clinical trials are efficient is crucial to minimising research ‘waste’, which most commonly results from the costs associated with poorly conceived research questions, inappropriate study design, failure to adequately report on all areas being analysed, and inefficient operational conduct.
Trial efficiency can be improved via two key mechanisms- by design and by conduct. Trial design involves the development and application of innovative statistical methods including adaptive and pragmatic designs. The first involves adapting some elements of the design as the trial progresses (rather than waiting for the trial to end). A pragmatic trial evaluates a health intervention in a setting as close as possible to real-world conditions. Adaptive designs help to gener
Centre for Sex and Gender Equity in Health and Medicine
The health of women and girls, people with variations in sex characteristics (intersex people) and trans and gender-diverse people has been understudied in health and medical research. An almost exclusive focus on male cells, male animals and men in health and medical research has led to poorer health outcomes and evidence gaps for women, intersex people, and trans and gender-diverse people, and inefficient health spending. Women’s health research often focuses only on their sexual, reproductive, and maternal health rather than the leading causes of death and disability for women. Research on intersex and gender-diverse people is even less developed and availability of health data remains a challenge. For some health conditions, we also have very little information on men and boys, given the conditions occur predominantly in women. The Centre for Sex and Gender Equity in Health and Medicine is addressing these inequities through world-class research, advocacy for policy change, and capacity building
FoodSwitch – Data on the world’s packaged foods
The purpose of FoodSwitch is to bring transparency to the world’s food supply with a vision of an optimised food system for human health and the health of our planet.
There are many studies highlighting the link between diet, ill-health and disease. Globally, 1 in 5 deaths are associated with poor diet, with cardiovascular disease being the biggest contributor, followed by cancers and type 2 diabetes. In addition, it is estimated that between 30% and 40% of anthropogenic greenhouse gas emissions (GHGe) are attributable to the global food system.
To achieve our purpose, we collect and analyse information from packaged food labels to generate data and insights that can influence government policy and industry practice toward improved food environments. Additionally, we have several apps that allow consumers to make better food choices:
Our FoodSwitch App provides simple health and nutrition information on a scanned product and suggests healthier alternatives to 'switch' to, and
The FoodSwitch data
Packaged food attribute data
The FoodSwitch database holds detailed nutrition and attribute information on individual packaged food products. The data is used for research and advocacy to influence government policy and industry practice toward improved food environments. It is also used by the various apps to help consumers make healthier food choices by offering accessible and clear information about the nutritional content of packaged foods. The database is continually updated, reflecting changes in food formulations and the introduction of new products – it is estimated that there is around 25% - 30% of product churn every 12 months. The data is utilised in various tools and apps to guide users towards healthier eating patterns, supporting public health initiatives and research on dietary habits and nutrition.
FoodSwitch: Tracking Food Data Across 17 Jurisdictions
AustraliaNew ZealandUnited KingdomSwedenFranceUSAMexicoBrazilChile
ChinaFijiHong KongIndiaKuwaitSouth A
Added sugar
Australians consume around 14 teaspoons of added sugar a day - two more than the 12 teaspoons limit recommended by the World Health Organisation (WHO). Eating too many foods high in added sugars can lead to weight gain, an increased risk of obesity related diseases, and is a major risk factor in tooth decay.
What is sugar?
Sugar is a type of carbohydrate that occurs naturally in foods such as milk and fruit and can also be added to foods and drinks in various forms by the manufacturer or the consumer.
Total sugars of a product refers to the combination of sugars that are naturally present and those that are added.Intrinsic and milk sugars occur in foods and drinks such as intact fruits and vegetables (i.e. fructose) and milk (i.e. lactose).Added sugars are all other sugars. It is these sugars that are associated with poor health outcomes and we should avoid. They are often added by manufacturers to give greater sweetness or other desired characteristics.
What is added sugar
World Safety 2024 event - building a safer future for all
The 15th World Conference on Injury Prevention and Safety Promotion (Safety 2024) co-sponsored by the World Health Organization will be held between 2nd-4th September 2024 at Taj Palace, New Delhi (India). This event will focus worldwide attention on safety and injury prevention. The event is hosted by The George Institute for Global Health in collaboration with three other WHO Collaborating Centres in the region:
Transportation Research and Injury Prevention Center (TRIP) at the Indian Institute of Technology (IIT) Delhi
Department of Emergency Medicine, All India Institute for Medical Sciences (AIIMS)
Department of Epidemiology, National Institute of Mental Health and Neuro Sciences (NIMHANS)
All the international experts in the field will gather at this event with a united goal of “Building a safer future for all: Equitable and sustainable strategies for injury and violence prevention”.
Why is the George Ins